A letter in The Lancet titled "HTLV III Antibody Screening of Blood Bank Donors" noted that with any screening test the problem lay with false positives. It was elucidated that this would have a significant impact both on blood supplies and on blood donors, as seropositive blood would be discarded and donors would be notified of their results.